Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03601897 |
|---|---|
| Brief Title: | A Phase 1b/2 Study of Rebastinib (DCC-2036) in Combination With Paclitaxel in Patients With Advanced or Metastatic Solid Tumors |
| First Submitted : | July 5, 2018 |
| First Submitted that Met QC Criteria : | July 25, 2018 |
| First Posted : | July 26, 2018 |
| Last Update Submitted that Met QC Criteria : | September 18, 2023 |
| Last Update Posted : | September 21, 2023 |